ATESSIA, Life Science Advisors

ATESSIA, Life Science Advisors is a Regulatory and Pharmaceutical Affairs consultancy based in France. Established in 2017, the company offers tailored advisory services for healthcare and pharmaceutical industries with a keen focus on regulatory strategy, pharmaceutical development, compliance, and quality management. ATESSIA's comprehensive range of services includes regulatory and pharmaceutical strategy, registration and electronic submission, pharmacovigilance, pharmaceutical development, compliance audits, quality management systems, advertising and promotion compliance, vigilance, and regulatory oversight for medical devices. The company prides itself on agility, attentive client engagement, and the excellence of its experts, aiming to provide guidance from product development to commercialization. Moreover, ATESSIA holds several accreditations including ISO 9001, CIR, Label PME EMA, and Qualiopi, showcasing its commitment to quality and compliance. Despite its promising potential, no information is available regarding the company's last investment or the investors involved. ATESSIA presents an intriguing opportunity for investors seeking to capitalize on the growing demand for specialized regulatory and pharmaceutical advisory services in the healthcare and pharmaceutical sectors in France and beyond. With its unique positioning and a comprehensive suite of offerings, it envisions becoming a valuable partner for companies navigating complex regulatory landscapes and driving transformative healthcare products to market.